These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9223532)

  • 1. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.
    Gupta P; Mellors J; Kingsley L; Riddler S; Singh MK; Schreiber S; Cronin M; Rinaldo CR
    J Virol; 1997 Aug; 71(8):6271-5. PubMed ID: 9223532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy.
    Ball JK; Rowe T; Curran R; Irving WL; Beards GM; Sontag G; Youle M; Moyle G; Pillay D
    Sex Transm Infect; 1999 Oct; 75(5):337-9. PubMed ID: 10616359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.
    Mayer KH; Boswell S; Goldstein R; Lo W; Xu C; Tucker L; DePasquale MP; D'Aquila R; Anderson DJ
    Clin Infect Dis; 1999 Jun; 28(6):1252-9. PubMed ID: 10451162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.
    Gilliam BL; Dyer JR; Fiscus SA; Marcus C; Zhou S; Wathen L; Freimuth WW; Cohen MS; Eron JJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 May; 15(1):54-60. PubMed ID: 9215655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
    Hammer SM; Vaida F; Bennett KK; Holohan MK; Sheiner L; Eron JJ; Wheat LJ; Mitsuyasu RT; Gulick RM; Valentine FT; Aberg JA; Rogers MD; Karol CN; Saah AJ; Lewis RH; Bessen LJ; Brosgart C; DeGruttola V; Mellors JW;
    JAMA; 2002 Jul; 288(2):169-80. PubMed ID: 12095381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.
    Craigo JK; Patterson BK; Paranjpe S; Kulka K; Ding M; Mellors J; Montelaro RC; Gupta P
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1196-209. PubMed ID: 15588342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.
    Taylor S; van Heeswijk RP; Hoetelmans RM; Workman J; Drake SM; White DJ; Pillay D
    AIDS; 2000 Sep; 14(13):1979-84. PubMed ID: 10997403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.
    Liuzzi G; Chirianni A; Clementi M; Bagnarelli P; Valenza A; Cataldo PT; Piazza M
    AIDS; 1996 Dec; 10(14):F51-6. PubMed ID: 8970677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs.
    Chan DJ; Ray JE; McNally L; Batterham M; Smith DE
    Curr HIV Res; 2008 Sep; 6(5):477-84. PubMed ID: 18855660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.
    Eron JJ; Vernazza PL; Johnston DM; Seillier-Moiseiwitsch F; Alcorn TM; Fiscus SA; Cohen MS
    AIDS; 1998 Oct; 12(15):F181-9. PubMed ID: 9814860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment.
    Pinto Neto LF; Vieira NF; Soprani M; Cunha CB; Cabral VP; Dietze R; Ribeiro-Rodrigues R
    Rev Soc Bras Med Trop; 2003; 36(6):689-94. PubMed ID: 15049108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
    Kuritzkes DR; Bassett RL; Johnson VA; Marschner IC; Eron JJ; Sommadossi JP; Acosta EP; Murphy RL; Fife K; Wood K; Bell D; Martinez A; Pettinelli CB
    AIDS; 2000 Jul; 14(11):1553-61. PubMed ID: 10983642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed.
    Bellman PC
    AIDS; 1998 Jul; 12(11):1333-40. PubMed ID: 9708413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection.
    Liuzzi G; Chirianni A; Bagnarelli P; Clementi M; Piazza M
    Antivir Ther; 1999; 4(2):95-9. PubMed ID: 10682154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.
    Deng SC; Chen MY; Hsieh SM; Sheng WH; Hsiao CF; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2003 Mar; 36(1):10-4. PubMed ID: 12741726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
    Lafeuillade A; Solas C; Halfon P; Chadapaud S; Hittinger G; Lacarelle B
    HIV Clin Trials; 2002; 3(1):27-35. PubMed ID: 11819183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.